Celldex Therapeutics buy Wells Fargo & Company
Start price
18:30
/
50%
€30.78
Target price
29.07.27
€63.18
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | - |
| iShares Core DAX® | 1.717% |
| iShares Nasdaq 100 | -4.565% |
| iShares Nikkei 225® | -7.120% |
| iShares S&P 500 | -0.894% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Wells Fargo & Company from $48.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.84
13.05.26
13.05.26
€46.01
13.05.27
13.05.27
12.25%
08:03
08:03
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
69.84%
08:03
08:03